DTM_5

RVPH - Breakout Imminent?

Long
NASDAQ:RVPH   Reviva Pharmaceuticals Holdings, Inc.
RVPH is within 8 weeks of reporting expected positive P3 results on a drug compound with blockbuster potential.

A great setup - Beautiful triangle formation is complete with a strong base. 200 day MA is easily within range.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.